Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
How do you image when using DIBH with breast treatment?
Do you use portal or orthogonal imaging or both?
Answer from: Radiation Oncologist at Academic Institution
For patients undergoing DIBH we use standard portal imaging only.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
VisionRT/OSMS daily with weekly standard ports
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
We use daily imaging of one tangential field . To minimize dose and exposure we only take one image of actual field and not double exposure with open field
Sign in or Register to read more
5160
5179
5178
Related Questions
What is your preferred PMRT dose/fractionation for patients with implant reconstruction?
How would you approach a non-healing wound following lumpectomy for recurrent disease in a patient who underwent breast conservation therapy with radiation 10 years prior?
Do you offer APBI for patients with invasive disease if there is high grade DCIS present in the lumpectomy specimen?
How would you manage a left sided triple negative breast cancer with a concurrent left sided locally advanced non-small cell lung cancer?
Would you offer reirradiation for a patient who had prior MammoSite PBI?
For which patients, if any, do you typically order additional imaging workup for staging in early-stage breast cancer?
Is a completion axillary dissection required for a patient with clinical N+ disease who had a complete clinical response in the axilla to neoadjuvant systemic therapy but is found to ypN+ disease on sentinel node biopsy?
Would you consider omitting PMRT in cT3N0 triple negative breast cancer with a pCR?
Would you consider radiation omission for a patient with a Stage I breast cancer with an elevated Oncotype Dx?
Would you offer RNI for young patient with cT3N0 triple negative breast cancer that had progression of disease during neoadjuvant chemotherapy, followed by mastectomy and sentinel node biopsy?